Compact Medical Secures $1M Phase II SBIR Grant from the NSF
In a significant leap towards transforming emergency medical care, Compact Medical has been awarded a rare $1 million Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). Building upon the company's groundbreaking work in Phase I, this grant not only acknowledges the company's innovative prowess but also provides the necessary resources to help finalize the research and development of the butterflyBVM.
Phase I Success
Compact Medical put taxpayer dollars to good use after receiving a Phase I SBIR from the NSF. Those funds moved the butterflyBVM from a high-level concept to a mature technology that better addresses the needs of the EMS community.
ButterflyBVM concept before start of NSF Phase I award.
ButterflyBVM design at the conclusion of the NSF Phase I award.
Compact Medical's Phase I efforts paid off and put the company in a competitive position for a Phase II award.
Moving Toward Commercialization
The $1 million Phase II SBIR grant from NSF serves as a pivotal moment for Compact Medical. While Phase I funds were vital in proving the concept of the butterflyBVM, additional resources are still needed to "round out the edges" of the technology, secure FDA approval, and prepare for launch. The grant will cover many of the costs needed to finalize development of the butterflyBVM, complete rigorous testing of the device, set up manufacturing in the United States, and prepare the device for submission to the US Food and Drug Administration (FDA).
The Significance of the Phase II SBIR Grant
The Phase II SBIR grant from NSF signifies more than just financial support; it represents a collective effort to revolutionize emergency respiratory care. Compact Medical's collaboration with NSF reflects the foundation's commitment to fostering innovation and advancing technologies that have the potential to transform lives. By providing vital resources, mentorship, and expertise, the NSF is empowering Compact Medical to bring the butterflyBVM into the critical-care market and save lives.
You can find the NSF's announcement of the award here.